Press Releases
Quaker Chemical Announces Fourth Quarter And Full Year 2014 Results
CONSHOHOCKEN, Pa.,
Mr. Barry continued, "2014 was the fifth consecutive year of increased revenue, operating income and adjusted EBITDA, which approximated
Mr. Barry continued, "Looking forward, we are seeing an uncertain economic environment in many countries throughout the world and a strong U.S. dollar. However, we remain committed to our strategy and believe our ability to take market share and leverage our acquisitions will continue to help offset forward market challenges. Overall, I continue to remain confident in our future and expect 2015 to be another good year for Quaker, as we strive to increase revenue, operating income and adjusted EBITDA for the sixth consecutive year."
Fourth Quarter of 2014 Summary
Net sales for the fourth quarter of 2014 of
Gross profit increased approximately
Selling, general and administrative expenses ("SG&A") increased approximately
Other income decreased approximately
Interest expense was consistent between the fourth quarter of 2014 and the fourth quarter of 2013. The Company incurred additional interest expense in the current quarter from higher average borrowings due to its recent acquisition activity, which was more than offset by prior year interest expense from the accretion of the acquisition-related earnout liability, noted above, that was settled in early 2014.
Interest income was
The Company's effective tax rates for the fourth quarters of 2014 and 2013 were 28.5% and 21.7%, respectively. During 2013, the Company's quarterly effective tax rates were impacted by its
Equity in net income of associated companies ("equity income") decreased
The
The Company's current year acquisitions generally performed in line with their expected positive operating results for the fourth quarter of 2014, however, these results were largely offset by the acquisition-related costs, noted above, and initial adjustments related to fair value accounting. Overall, the impact from the current year acquisitions to the Company's net income was slightly positive at less than
Changes in foreign exchange rates negatively impacted the fourth quarter of 2014 net income by approximately
Year-to-Date 2014 Summary
Net sales for 2014 of
Gross profit increased approximately
SG&A increased approximately
The
Interest expense was
Interest income was
The Company's effective tax rates for 2014 and 2013 were 30.1% and 28.1%, respectively. The primary contributor to the Company's higher effective tax rate in 2014 was an increase in reserves related to uncertain tax positions.
The decrease in the Company's equity income of
The primary component of the
The Company's current year acquisitions generally performed in line with their expected positive operating results for 2014, however, these results were largely offset by the acquisition-related costs, noted above, and initial adjustments related to fair value accounting. Overall, the impact from the current year acquisitions to the Company's net income was slightly positive at less than
Changes in foreign exchange rates negatively impacted the 2014 net income by approximately
Balance Sheet and Cash Flow Items
The Company's net operating cash flow for the fourth quarter of 2014 was approximately
Non-GAAP Measures
Included in this public release are non-GAAP financial measures of non-GAAP earnings per diluted share and adjusted EBITDA. The Company believes these non-GAAP financial measures provide meaningful supplemental information as they enhance a reader's understanding of the financial performance of the Company, are more indicative of future operating performance of the Company, and facilitate a better comparison among fiscal periods, as the non-GAAP financial measures exclude items that are not considered core to the Company's operations. Non-GAAP results are presented for supplemental informational purposes only and should not be considered a substitute for the financial information presented in accordance with GAAP.
The following are reconciliations between the non-GAAP (unaudited) financial measures of non-GAAP earnings per diluted share and adjusted EBITDA to their most directly comparable GAAP financial measures:
Three Months Ended December 31, |
Twelve Months Ended December 31, | |||||||
2014 |
2013 |
2014 |
2013 | |||||
GAAP earnings per diluted share attributable to Quaker Chemical Corporation Common Shareholders |
$ 0.95 |
$ 1.07 |
$ 4.26 |
$ 4.27 | ||||
UK pension plan amendment per diluted share |
— |
— |
0.05 |
— | ||||
Customer bankruptcy costs per diluted share |
0.03 |
— |
0.05 |
— | ||||
Mineral oil excise tax refund per diluted share |
— |
— |
— |
(0.14) | ||||
Change in acquisition-related earnout liability per diluted share |
— |
(0.06) |
— |
(0.03) | ||||
Cost streamlining initiatives per diluted share |
0.04 |
0.01 |
0.06 |
0.08 | ||||
Currency conversion impacts of the Venezuelan Bolivar Fuerte |
— |
— |
0.02 |
0.03 | ||||
Non-income tax contingency charge per diluted share |
— |
0.04 |
— |
0.04 | ||||
Equity income in a captive insurance company per diluted share |
(0.02) |
(0.08) |
(0.18) |
(0.41) | ||||
Non-GAAP earnings per diluted share |
$ 1.00 |
$ 0.98 |
$ 4.26 |
$ 3.84 |
Three Months Ended December 31, |
Twelve Months Ended December 31, | |||||||
2014 |
2013 |
2014 |
2013 | |||||
Net income attributable to Quaker Chemical Corporation |
$ 12,639 |
$ 14,086 |
$ 56,492 |
$ 56,339 | ||||
Depreciation and amortization |
4,723 |
3,944 |
16,631 |
15,784 | ||||
Interest expense |
624 |
699 |
2,371 |
2,922 | ||||
Taxes on income before equity in net income of associated companies |
4,731 |
3,556 |
23,539 |
20,489 | ||||
UK pension plan amendment |
— |
— |
902 |
— | ||||
Customer bankruptcy costs |
515 |
— |
825 |
— | ||||
Mineral oil excise tax refund |
— |
— |
— |
(2,540) | ||||
Change in acquisition-related earnout liability |
— |
(1,172) |
— |
(497) | ||||
Cost streamlining initiatives |
818 |
142 |
1,166 |
1,419 | ||||
Currency conversion impacts of the Venezuelan Bolivar Fuerte |
— |
— |
321 |
357 | ||||
Non-income tax contingency charge |
— |
796 |
— |
796 | ||||
Equity income in a captive insurance company |
(270) |
(1,073) |
(2,412) |
(5,451) | ||||
Adjusted EBITDA |
$ 23,780 |
$ 20,978 |
$ 99,835 |
$ 89,618 | ||||
Forward-Looking Statements
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected in such statements. A major risk is that the Company's demand is largely derived from the demand for its customers' products, which subjects the Company to downturns in a customer's business and unanticipated customer production shutdowns. Other major risks and uncertainties include, but are not limited to, significant increases in raw material costs, customer financial stability, worldwide economic and political conditions, foreign currency fluctuations, future terrorist attacks and other acts of violence. Other factors could also adversely affect us. Therefore, we caution you not to place undue reliance on our forward-looking statements. This discussion is provided as permitted by the Private Securities Litigation Reform Act of 1995.
Conference Call
As previously announced,
About Quaker
Quaker Chemical Corporation | ||||||||
Consolidated Statements of Income | ||||||||
(Dollars in thousands, except per share data) | ||||||||
Three Months Ended December 31, |
Twelve Months Ended December 31, | |||||||
2014 |
2013 |
2014 |
2013 | |||||
Net sales |
$ 194,033 |
$ 184,297 |
$ 765,860 |
$ 729,395 | ||||
Cost of goods sold |
124,457 |
119,134 |
492,654 |
468,320 | ||||
Gross profit |
69,576 |
65,163 |
273,206 |
261,075 | ||||
% |
35.9% |
35.4% |
35.7% |
35.8% | ||||
Selling, general and administrative expenses |
53,091 |
49,931 |
195,850 |
189,832 | ||||
Operating income |
16,485 |
15,232 |
77,356 |
71,243 | ||||
% |
8.5% |
8.3% |
10.1% |
9.8% | ||||
Other income, net |
209 |
1,557 |
767 |
3,519 | ||||
Interest expense |
(624) |
(699) |
(2,371) |
(2,922) | ||||
Interest income |
551 |
321 |
2,541 |
986 | ||||
Income before taxes and equity in net income of associated companies |
16,621 |
16,411 |
78,293 |
72,826 | ||||
Taxes on income before equity in net income of associated companies |
4,731 |
3,556 |
23,539 |
20,489 | ||||
11,890 |
12,855 |
54,754 |
52,337 | |||||
Equity in net income of associated companies |
1,037 |
1,825 |
3,543 |
6,514 | ||||
Net income |
12,927 |
14,680 |
58,297 |
58,851 | ||||
Less: Net income attributable to noncontrolling interest |
288 |
594 |
1,805 |
2,512 | ||||
Net income attributable to Quaker Chemical Corporation |
$ 12,639 |
$ 14,086 |
$ 56,492 |
$ 56,339 | ||||
% |
6.5% |
7.6% |
7.4% |
7.7% | ||||
Per share data: |
||||||||
Net income attributable to Quaker Chemical Corporation Common Shareholders - basic |
$ 0.95 |
$ 1.07 |
$ 4.27 |
$ 4.28 | ||||
Net income attributable to Quaker Chemical Corporation Common Shareholders - diluted |
$ 0.95 |
$ 1.07 |
$ 4.26 |
$ 4.27 |
Quaker Chemical Corporation | ||||
Consolidated Balance Sheets | ||||
(Dollars in thousands, except par value and share amounts) | ||||
December 31, |
December 31, | |||
2014 |
2013 | |||
ASSETS |
||||
Current assets |
||||
Cash and cash equivalents |
$ 64,731 |
$ 68,492 | ||
Accounts receivable, net |
189,484 |
165,629 | ||
Inventories, net |
77,708 |
71,557 | ||
Current deferred tax assets |
8,367 |
7,826 | ||
Prepaid expenses and other current assets |
11,228 |
15,343 | ||
Total current assets |
351,518 |
328,847 | ||
Property, plant and equipment, net |
85,763 |
85,488 | ||
Goodwill |
77,933 |
58,151 | ||
Other intangible assets, net |
70,408 |
31,272 | ||
Investments in associated companies |
21,751 |
19,397 | ||
Non-current deferred income taxes |
24,411 |
24,724 | ||
Other assets |
33,742 |
36,267 | ||
Total assets |
$ 665,526 |
$ 584,146 | ||
LIABILITIES AND EQUITY |
||||
Current liabilities |
||||
Short-term borrowings and current portion of long-term debt |
$ 403 |
$ 1,395 | ||
Accounts payable |
74,987 |
72,281 | ||
Dividends payable |
3,990 |
3,299 | ||
Accrued compensation |
19,853 |
20,801 | ||
Accrued pension and postretirement benefits |
1,239 |
1,438 | ||
Current deferred tax liabilities |
732 |
1,057 | ||
Other current liabilities |
23,697 |
30,585 | ||
Total current liabilities |
124,901 |
130,856 | ||
Long-term debt |
75,328 |
17,321 | ||
Non-current deferred income taxes |
8,584 |
6,729 | ||
Non-current accrued pension and postretirement benefits |
46,088 |
37,006 | ||
Other non-current liabilities |
45,490 |
47,538 | ||
Total liabilities |
300,391 |
239,450 | ||
Equity |
||||
Common stock, $1 par value; authorized 30,000,000 |
13,301 |
13,196 | ||
Capital in excess of par value |
99,056 |
99,038 | ||
Retained earnings |
299,524 |
258,285 | ||
Accumulated other comprehensive loss |
(54,406) |
(34,700) | ||
Total Quaker shareholders' equity |
357,475 |
335,819 | ||
Noncontrolling interest |
7,660 |
8,877 | ||
Total equity |
365,135 |
344,696 | ||
Total liabilities and equity |
$ 665,526 |
$ 584,146 |
Quaker Chemical Corporation | ||||
Consolidated Statements of Cash Flows | ||||
For the twelve months ended December 31, | ||||
(Dollars in thousands) | ||||
2014 |
2013 | |||
Cash flows from operating activities |
||||
Net income |
$ 58,297 |
$ 58,851 | ||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||
Depreciation |
12,306 |
12,339 | ||
Amortization |
4,325 |
3,445 | ||
Equity in undistributed earnings of associated companies, net of dividends |
(3,180) |
(4,162) | ||
Deferred income taxes |
1,007 |
(30) | ||
Uncertain tax positions (non-deferred portion) |
(1,256) |
(1,826) | ||
Acquisition-related fair value adjustments |
- |
200 | ||
Deferred compensation and other, net |
3,174 |
(259) | ||
Stock-based compensation |
5,309 |
4,161 | ||
(Gain) loss on disposal of property, plant and equipment |
(86) |
200 | ||
Insurance settlements realized |
(1,907) |
(988) | ||
Pension and other postretirement benefits |
1,265 |
862 | ||
(Decrease) increase in cash from changes in current assets and current liabilities, net of |
||||
Accounts receivable |
(24,944) |
(11,837) | ||
Inventories |
(5,484) |
406 | ||
Prepaid expenses and other current assets |
2,003 |
(743) | ||
Accounts payable and accrued liabilities |
2,999 |
11,301 | ||
Estimated taxes on income |
862 |
1,881 | ||
Net cash provided by operating activities |
54,690 |
73,801 | ||
Cash flows from investing activities |
||||
Investments in property, plant and equipment |
(13,052) |
(11,439) | ||
Payments related to acquisitions, net of cash acquired |
(73,527) |
(2,478) | ||
Proceeds from disposition of assets |
201 |
513 | ||
Interest earned on an Insurance settlement |
44 |
52 | ||
Change in restricted cash, net |
1,863 |
936 | ||
Net cash used in investing activities |
(84,471) |
(12,416) | ||
Cash flows from financing activities |
||||
Proceeds from long-term debt |
58,771 |
- | ||
Repayments of long-term debt |
(1,368) |
(12,791) | ||
Dividends paid |
(14,562) |
(13,018) | ||
Stock options exercised, other |
804 |
(307) | ||
Excess tax benefit related to stock option exercises |
453 |
815 | ||
Purchase of noncontrolling interest in affiliates, net |
(7,422) |
- | ||
Payment of acquisition-related earnout liability |
(4,709) |
- | ||
Distributions to noncontrolling affiliate shareholders |
(1,806) |
(905) | ||
Net cash provided by (used in) financing activities |
30,161 |
(26,206) | ||
Effect of exchange rate changes on cash |
(4,141) |
766 | ||
Net (decrease) increase in cash and cash equivalents |
(3,761) |
35,945 | ||
Cash and cash equivalents at the beginning of the period |
68,492 |
32,547 | ||
Cash and cash equivalents at the end of the period |
$ 64,731 |
$ 68,492 |
Logo - http://photos.prnewswire.com/prnh/20120910/PH70044LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/quaker-chemical-announces-fourth-quarter-and-full-year-2014-results-300042366.html
SOURCE
Margaret M. Loebl, Vice President, Chief Financial Officer and Treasurer, loeblm@quakerchem.com, T. 610.832.4160